Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHE/300558 stock hub

SHE/300558 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/300558is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

21.6B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/300558

In the news

Latest news · SHE/300558

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E27.5

P25 17.1P50 24.2P75 37.8

Trailing P/E48.9

P25 23.5P50 41.3P75 83.2

ROE6.8

P25 -0.9P50 4.1P75 8.8

ROIC5.1

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/300558 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

231

Groups with data

Currency

CNY

Showing 231 of 231 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	1,785
Employees Change	89%
Employees Change Percent	5.25
Enterprise value	CNY 23.8B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE100002DD9
Last refreshed	2026-05-10
Market cap	CNY 21.6B
Price	CNY 51.44
Price currency	CNY
Rev Per Employee	2,090,543.1x
Sector	Healthcare
Sic	2834
Symbol	she/300558
Website	https://www.bettapharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.04%
EV Earnings	53.86x
EV/EBIT	38.75x
EV/EBITDA	19.66x
EV/FCF	233.95x
EV/Sales	6.37x
FCF yield	0.47%
Forward P/E	27.51x
P/B ratio	3.15x
P/E ratio	48.89x
P/S ratio	5.8x
PE Ratio10 Y	88.32x
PE Ratio3 Y	61.11x
PE Ratio5 Y	81.79x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	16.43%
EBITDA Margin	32.32%
FCF margin	2.72%
Gross margin	78.98%
Gross Profit	CNY 2.9B
Gross Profit Growth	18.27%
Gross Profit Growth Q	10.27%
Gross Profit Growth3 Y	12.92%
Gross Profit Growth5 Y	11.51%
Net Income	CNY 441.2M
Net Income Growth	9.06%
Net Income Growth Q	135.71%
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Net Income Growth3 Y	57.4%
Net Income Growth5 Y	-6.69%
Pretax Margin	15.37%
Profit Margin	11.82%
Profit Per Employee	CNY 247,147
Profitable Years	15
ROA	3.87
Roa5y	2.86
ROCE	6.81
ROE	6.75
Roe5y	5.86
ROIC	5.14
Roic5y	6.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	1.19%
Cagr3y	-7.97%
Cagr5y	-11.98%
Div CAGR3	41.64%
Div CAGR5	-8.49%
EPS Growth	8.44
EPS Growth Q	133.3
EPS Growth Quarters	2
EPS Growth Years	0
EPS Growth3 Y	57.3
EPS Growth5 Y	-7.08
FCF Growth	-60.14%
OCF Growth	-8.75%
OCF Growth Q	-11.4%
OCF Growth10 Y	12.2%
OCF Growth3 Y	28.3%
OCF Growth5 Y	14.85%
Revenue Growth	21.4x
Revenue Growth Q	13.33x
Revenue Growth Quarters	7x
Revenue Growth Years	8x
Revenue Growth3 Y	17.11x
Revenue Growth5 Y	15.17x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.38
Assets	CNY 10.7B
Cash	CNY 510.2M
Current Assets	CNY 1.7B
Current Liabilities	CNY 1.7B
Debt	CNY 2.6B
Debt EBITDA	CNY 2.12
Debt Equity	CNY 0.37
Debt FCF	CNY 25.22
Equity	CNY 6.9B
Interest Coverage	8.46
Liabilities	CNY 3.8B
Long Term Assets	CNY 9B
Long Term Liabilities	CNY 2.1B
Net Cash	CNY -2.1B
Net Cash By Market Cap	CNY -9.48
Net Debt EBITDA	CNY 1.7
Net Debt Equity	CNY 0.3
Net Debt FCF	CNY 20.19
Tangible Book Value	CNY 3.6B
Tangible Book Value Per Share	CNY 8.63
WACC	6.8

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.99
Inventory Turnover	2.4
Net Working Capital	CNY 280.3M
Quick ratio	0.62
Working Capital	CNY -15.9M
Working Capital Turnover	CNY -9.25

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.57%
Dividend Growth	17.02%
Dividend Growth Years	2%
Dividend per share	CNY 0.15
Dividend Years	9
Dividend Yield	0.29%
Ex Div Date	2025-06-17
Last Dividend	CNY 0.2
Payout Frequency	Annual
Payout Ratio	33.4%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	1.19%
200-day SMA	54.38
3Y total return	-22.05%
50-day SMA	45.15
50-day SMA vs 200-day SMA	50under200
5Y total return	-47.17%
All Time High	160.7
All Time High Change	-67.98%
All Time High Date	2020-07-13
All Time Low	23.19
All Time Low Change	121.82%
All Time Low Date	2016-11-07
ATR	2.03
Beta	0.57
Beta1y	0.28
Beta2y	0.28
Ch YTD	10.17
High	53.29
High52	79.8
High52 Date	2025-09-02
High52ch	-35.54%
Low	51.2
Low52	40.1
Low52 Date	2026-03-23
Low52ch	28.28%
Ma50ch	13.94%
Price vs 200-day SMA	-5.41%
RSI	64.03
RSI Monthly	49.23
RSI Weekly	55.5
Sharpe ratio	0.19x
Sortino ratio	0.45
Total Return	-0.28%
Tr YTD	10.17
Tr1m	15.65%
Tr1w	-2.85%
Tr3m	8.98%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 613.2M
Operating Income Growth	6.03
Operating Income Growth Q	32.53
Operating Income Growth3 Y	67.17
Operating Income Growth5 Y	8.33
Operating margin	16.43

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	236,721,883%
Net Borrowing	206,961,290
Shares Insiders	2.59%
Shares Institutions	19.69%
Shares Out	420,733,843
Shares Qo Q	-0.17%
Shares Yo Y	0.57%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 101.6M
Average Volume	12,570,970.35x
Bv Per Share	16.15
CAPEX	CNY -775.8M
Ch1m	15.65
Ch1w	-2.85
Ch1y	0.86
Ch3m	8.98
Ch3y	-22.76
Ch5y	-47.95
Ch6m	-5.14
Change	-2.87%
Change From Open	-2.17
Close	52.96
Days Gap	-0.72
Depreciation Amortization	592,878,827
Dollar Volume	565,989,227.4
Earnings Date	2026-04-23
EBIT	CNY 613.2M
EBITDA	CNY 1.2B
EPS	CNY 1.05
F Score	6
FCF	CNY 101.6M
FCF EV Yield	0.43x
FCF Per Share	CNY 0.24
Financing CF	81,830,129
Fiscal Year End	December
Founded	2,003
Goodwill	413,584,000
Graham Number	19.55246
Graham Upside	-61.99
Income Tax	CNY 151.8M
Investing CF	-1,087,000,842
Is Primary Listing	1
Last Earnings Date	2026-04-23
Last Report Date	2026-03-31
Lynch Fair Value	CNY 5.26
Lynch Upside	-89.77
Ma150	50.19
Ma150ch	2.5%
Ma20	47.24
Ma20ch	8.89%
Net CF	-127,129,898
Open	52.58
P FCF Ratio	213.1
P OCF Ratio	24.67
Payment Date	2025-06-17
Position In Range	11.48
Ppne	2,926,031,959
Price Date	2026-05-08
Price EBITDA	CNY 17.94
Ptbv Ratio	5.96
Relative Volume	0.89x
Revenue	3,731,619,436x
Tax By Revenue	4.07x
Tax Rate	26.46%
Tr6m	-5.14%
Volume	11,002,901
Z Score	4.61

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/300558 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.3%

$0.15 annual per share

Payout ratio

+33.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-8.5%

2 consecutive years of growth

Total shareholder yield

-0.3%

Next ex-dividend date: 2025-06-17

Performance

SHE/300558 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/300558?

Insider, institutional, and short-interest positioning.

Institutional ownership

+19.7%

Share of float held by funds and institutions

Insider ownership

+2.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.6%

Negative means the company is buying back shares.

Technical

SHE/300558 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

64.0

Neutral momentum band

Price vs 200-day MA

-5.4%

50/200-day relationship not available

Beta (5Y)

0.57

Less volatile than the market

Sharpe ratio

0.19

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/300558

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/300558 stock rating?

she/300558 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/300558 analysis?

The full report lives at /stocks/she/300558/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/300558?

The latest report frames she/300558 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/300558 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.